Intas Pharmaceuticals
Ashish Kaushal is an experienced pharmaceutical executive currently serving as Vice President of Commercial Strategy at Intas Pharmaceuticals since May 2024. Prior to this role, Ashish worked at Zydus Group for over 15 years, where responsibilities included Senior General Manager and Head of Marketing and Sales for the Ziva Division in Dermatology. Ashish's career journey includes significant positions at Ranbaxy, Torrent Pharmaceuticals Ltd, and Nicholas Piramal India Limited, focusing on strategic marketing and brand management. Educational qualifications include an Adapt General Management Program from the Indian Institute of Management Ahmedabad, an MBA in Marketing from Apeejay School of Management, and a Bachelor's Degree in Pharmacy from K.L.E. College of Pharmacy.
This person is not in the org chart
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.